Insider filing · BBIO
Henry R Kravis
Co-Executive Chairman
profile →
BridgeBio Pharma, Inc.
BBIO · Healthcare · 71 filings in 24 months
ticker →
Henry R Kravis sold $205.2M of BridgeBio Pharma (BBIO)
Executed May 12 2025, disclosed May 14 2025, 2 days later.
Value, as filed
$205.2M
6,000,000 sh × $34.20
Executed
May 12 2025
the trade date, as filed
Disclosed
May 14 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
HKHenry R Kravis (Co-Executive Chairman) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in BrightSpring Health Services, Inc. (BTSG). The largest single filing was $857.4M of BTSG (14,669,771 sh × $58.45, as filed), executed Jun 5.
The name
BBIOHealthcare · BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→